FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the area of medicine and pharmaceutic and concerns to the anticoagulant containing, mass. %: arginine - 20.0-24.0, leucine - 28.0-30.0, heparin with the activity 80-120 I.U. per gram- the rest.
EFFECT: invention provides the increasing of efficiency of the target product resulting in the increasing of anticoagulant and fibrinolytic activities.
4 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTICOAGULANT | 2016 |
|
RU2616526C1 |
METHOD FOR PREVENTING HYPERCOAGULATION IN ANIMALS UNDER STRESS | 2019 |
|
RU2741948C1 |
HIGH-MOLECULAR HEPARIN COMPOSITION WITH ANTICOAGULANT, ANTI-PLATELET, FIBRINOLYTIC AND FIBRIN DEPOLYMERISATION PROPERTIES | 2011 |
|
RU2456993C1 |
HIGH-MOLECULAR HEPARIN COMPOSITION WITH ANTICOAGULANT, ANTI-PLATELET, FIBRINOLYTIC AND FIBRIN DEPOLYMERISATION PROPERTIES | 2011 |
|
RU2454237C1 |
ANTITHROMBOTIC COMPLEX BASED ON HEPARIN, METHOD OF ITS PRODUCTION AND USE | 2015 |
|
RU2600817C2 |
METHOD FOR MAKING ANTICOAGULANT-FIBRINOLYTIC HEPARIN PREPARATION | 2011 |
|
RU2448717C1 |
ANTICOAGULANT, ANTIPLATELET AND FIBRIN-DEPOLYMERIZATION COMPLEX BASED ON HEPARIN, METHOD OF ITS PRODUCTION AND USE | 2015 |
|
RU2606836C2 |
ANTITHROMBOTIC COMPOSITION ON BASIS OF HEPARIN FOR PERORAL APPLICATION | 2008 |
|
RU2359681C1 |
PEPTIDE POSSESSING ANTICOAGULANT, FIBRIN-DEPOLYMERIZING, ANTI-THROMBOSIS AND FIBRINOLYTIC ACTIVITIES | 2005 |
|
RU2289423C1 |
METHOD FOR OBTAINING HEMOSTATIC COMPOSITION | 2021 |
|
RU2790831C2 |
Authors
Dates
2017-02-10—Published
2016-02-17—Filed